Skip to main content

Is biogen.com a Scam? Security Check Results - Biogen

biogen.com Security Report Summary

biogen.com received a security score of 76 out of 100 in Guard's comprehensive security analysis, classified as "Moderate Risk". This report covers Biogen's website security posture. Biogen operates in the Healthcare industry in United States.

Biogen is a leading biotechnology company specializing in pioneering innovative science to develop new medicines that transform patients' lives. The company maintains a strong market position with a comprehensive portfolio focused on neurological and rare diseases. Their website reflects a mature digital presence with detailed information on disease areas, scientific innovation, medicines, corporate responsibility, and career opportunities. Technically, the site leverages Adobe Experience Manager as its CMS, integrates modern analytics and tag management tools, and implements a robust cookie consent mechanism, indicating a good level of digital maturity. Security posture is solid with HTTPS enforced and no exposed sensitive data, though the absence of explicit security headers and a public security policy suggests room for improvement. The WHOIS data is notably absent, which is unusual for a large enterprise and slightly impacts trustworthiness. Overall, the website is professional, well-structured, and compliant with privacy regulations, serving its diverse audience effectively.

The security scan identified 23 findings across security headers, SSL/TLS, DNS health, email security, GDPR compliance, and NIS2 compliance analysis modules.

Technologies detected: jQuery 3.6.4, Adobe Helix RUM, Google Tag Manager, Cookiebot, Adobe Analytics.

About this security scan

Guard performs automated security assessments of websites by analyzing SSL/TLS certificates, HTTP security headers, DNS configuration, email authentication protocols (SPF, DKIM, DMARC), GDPR compliance indicators, NIS2 directive compliance, network exposure, and business-context intelligence. Each report provides domain-specific findings, risk scores, and actionable recommendations.

biogen.com favicon

Is biogen.com Safe? Security Analysis for Biogen

https://biogen.com

Check if biogen.com is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Statesenterprise
jQuery 3.6.4Adobe Helix RUMGoogle Tag ManagerCookiebotAdobe Analytics
Analyzed Completed
76
Security Score
LOW RISK

Above Healthcare avg (65)

GDPR-aligned

Data handling

EU

Hosting region

EveryPay

Secure checkout

Instant

Reports delivered

Professional Report

Unlock the full report for biogen.com

Professional PDF, email delivery, and optional intelligence add-ons. One-time purchase, lifetime access.

Optional add-ons

via BREACH

Your order

Full Report
PDF · email delivery · lifetime access
39.90
Total
Incl. 21% VAT
39.90
Already purchased? Enter unlock code
VisaMastercardApple PayGoogle Payvia EveryPay
SEQ SIA
Reg. No. 40203410806 · VAT LV40203410806

AI Summary

Biogen is a leading biotechnology company specializing in pioneering innovative science to develop new medicines that transform patients' lives. The company maintains a strong market position with a comprehensive portfolio focused on neurological and rare diseases. Their website reflects a mature digital presence with detailed information on disease areas, scientific innovation, medicines, corporate responsibility, and career opportunities. Technically, the site leverages Adobe Experience Manager as its CMS, integrates modern analytics and tag management tools, and implements a robust cookie consent mechanism, indicating a good level of digital maturity. Security posture is solid with HTTPS enforced and no exposed sensitive data, though the absence of explicit security headers and a public security policy suggests room for improvement. The WHOIS data is notably absent, which is unusual for a large enterprise and slightly impacts trustworthiness. Overall, the website is professional, well-structured, and compliant with privacy regulations, serving its diverse audience effectively.

Detected Technologies

jQuery 3.6.4Adobe Helix RUMGoogle Tag ManagerCookiebotAdobe Analytics

5 urgent findings need attention

5 high

Continuous monitoring

Keep biogen.com under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay
Less than 1 € / day — cheaper than a single incident response hour

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Purchase to access the monitoring timeline, JSON diffs, alert history, and PDF export for biogen.com.

Security Headers

1 finding

95/100

GDPR Compliance

2 findings

83/100

NIS2 Compliance

8 findings

17/100

Email Security

3 findings

85/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Business Intelligence

Market & Strategic Analysis

Biogen operates in the healthcare sector with a focus on biotechnology and pharmaceuticals. Their business model centers on research and development of innovative therapies, clinical trials, and manufacturing of medicines. The company targets patients, healthcare professionals, investors, and partners globally, supported by localized country sites. Their market positioning as a leader is reinforced by extensive content on disease areas and scientific expertise. Partnerships include regional sites and job platforms. The website's comprehensive content and clear navigation support strong brand credibility and customer engagement. Growth indicators include active clinical trials and early access programs. The company demonstrates a commitment to corporate responsibility and inclusion, enhancing its market reputation.

Extracted Contact Information

Marketing Intelligence Data

Security Posture Analysis

Comprehensive Security Assessment

The website demonstrates a mature security posture with HTTPS enforced and a cookie consent mechanism aligned with GDPR requirements. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, the lack of explicit security headers such as Content-Security-Policy and X-Frame-Options is a gap that could be addressed to enhance protection against common web attacks. The absence of a published security policy or incident response information limits transparency and preparedness perception. No vulnerability disclosure program or security.txt file was found, which are recommended best practices for enterprise websites. Overall, the security posture is good but could be strengthened with additional controls and transparency.

Strategic Recommendations

Priority Actions for Security Improvement

1

Implement and publish comprehensive security headers including Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.

Observations

Comprehensive website and business-context analysis.

AI-Enhanced Website Analysis

Business Insights

Company:

Biogen

Description:

Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

Key Services:
Research and DevelopmentInnovative MedicinesClinical TrialsAccess ProgramsManufacturing
Content Quality:

excellent

Branding:

consistent

Technical Stack

Technologies:
jQuery 3.6.4Adobe Helix RUMGoogle Tag ManagerCookiebotAdobe Analytics
Frameworks:
Adobe Experience Manager (AEM)
Performance:

moderate

Mobile:

good

Accessibility:

good

SEO:

good

Security Assessment

Security Score:
85/100
Best Practices:
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data found in HTML

Analytics & Tracking

Services:
Adobe AnalyticsGoogle Analytics
Tracking Level:moderate
Privacy Compliance:good

Advertising & Marketing

Ad Networks:
Meta Platforms, Inc.
Tracking Pixels:
obs.seaskypro.comwww.ingenuityinsightful-52.com
Marketing Tools:
Cookiebot
Transparency Level:good

Website Quality Assessment

Design Quality:excellent
User Experience:excellent
Content Relevance:excellent
Navigation Clarity:excellent
Professionalism:excellent
Trustworthiness:high

Key Observations

1

Comprehensive corporate website with detailed sections on disease areas, science, medicines, responsibility, company info, and careers.

Get this report delivered to your inbox

Receive a summary of the biogen.com security findings by email. Quick and easy to share with decision makers.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Security Headers

HTTP security headers analysis

95/100
Score

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

GDPR Compliance

Privacy and data protection assessment

83/100
Score

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy85% confidence
Contact Information Found90% confidence
emailphone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

NIS2 Compliance

Network & Information Security Directive

17/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity

No security contact information

HIGH

NIS2 requires clear incident reporting channels

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts

Need this report as a PDF?

Download the complete biogen.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Email Security

SPF, DKIM, and DMARC validation

85/100
Score

No BIMI Record

LOW

BIMI displays brand logos in email clients

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 include:_u.biogen.com._spf.smart.ondmarc.com ~all
DNS Lookups:1/10
Policy:~all
DKIM Selectors Found
Selector:k1(1296-bit rsa)
Selector:k2(1416-bit rsa)
Selector:selector1(1296-bit rsa)
Selector:s1(1440-bit rsa)
DMARC Details
Policy:reject
Aggregate Reports:[email protected]
Forensic Reports:[email protected]

🏆SSL/TLS Security

Certificate validity and encryption analysis.

SSL/TLS Security

Certificate validity and encryption analysis

69/100
Score

Weak Protocols Supported

HIGH

Server supports weak protocols: TLSv1.1

OCSP Stapling Not Enabled

LOW

OCSP stapling improves performance and privacy

Certificate Transparency Not Implemented

LOW

Certificate is not logged in Certificate Transparency logs

SSL Certificate Expires Within 90 Days

MEDIUM

SSL certificate expires in 68 days

HSTS Missing includeSubDomains

LOW

HSTS header does not include subdomains

Protocol Support

TLSv1.3TLSv1.2TLSv1.1

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

DNS Health

DNS configuration and security assessment

80/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found

Domain Delete Lock Not Enabled

LOW

Domain can be deleted without additional verification

Domain Registration Details

Domain Age
31 years(mature)
Expiry Risk
low(253 days)
Protection Level
basicDNSSEC OFF

DNS Records

A Records:34.225.30.22, 18.235.216.236
Name Servers:
ns-1062.awsdns-04.org
ns-1947.awsdns-51.co.uk
ns-446.awsdns-55.com
ns-992.awsdns-60.net
MX Records:
0: biogen-com.mail.protection.outlook.com
SOA:Serial: 1, TTL: 86400s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:32ms

SPF Analysis

SPF Record:
v=spf1 include:_u.biogen.com._spf.smart.ondmarc.com ~all

Network Security

Port scanning and network exposure analysis.

Network Security

Port scanning and network exposure analysis

100/100
Score

Good Network Security Posture

LOW

No unnecessary services detected on common risky ports

How does biogen.com compare?

See how biogen.com stacks up against similar websites in the same industry.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

The website is built on Adobe Experience Manager, a robust enterprise CMS, and uses modern JavaScript libraries including jQuery 3.6.4. It integrates Google Tag Manager and Adobe Analytics for data collection and performance monitoring. Cookiebot is used for cookie consent management, ensuring GDPR compliance. The site is mobile optimized with responsive design and good accessibility features. Performance is moderate, with asynchronous loading of scripts and deferred CSS. Some external domains used for tracking and analytics may pose privacy considerations. The site lacks explicit security headers which could improve security posture. Overall, the technical infrastructure supports a professional and scalable digital presence with opportunities for security enhancements.
Professional Report

Download the biogen.com report as PDF

Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.

Optional add-ons

via BREACH

Your order

Full Report
PDF · email delivery · lifetime access
39.90
Total
Incl. 21% VAT
39.90
Already purchased? Enter unlock code
VisaMastercardApple PayGoogle Payvia EveryPay
SEQ SIA
Reg. No. 40203410806 · VAT LV40203410806

Scan your own website

Liked the biogen.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.

Or browse our directory of >10,000 scanned websites.

⭐ Verified Community Reviews

What others say about biogen.com

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website